Cogent Biosciences(COGT)

14.90 -0.27 -1.7798%

今开:15.23昨收:15.17
最高:15.45 最低:14.71
涨停价:0.0跌停价:0.0
总市值:1.041412167E9

Cogent Biosciences的新闻

Cogent Biosciences(COGT)宣布发行1.25亿美元的普通股

Cogent Biosciences(COGT)宣布已开始承销公开发行1.25亿美元的普通股。Cogent打算将此次发行的净收益用于与bezuclastinib和其他候选产品相关的开发、监管和商业准备活动,以及营运资金和一般公司用途。Jefferies、Piper Sandler& Co.和Gugge... 网页链接

Cogent Biosciences的公告

超过5%股东持股披露

$Cogent Biosciences(COGT)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0000093751-23-000162 Act: 34 Size: 8 KB 网页链接

超过5%股东持股披露

$Cogent Biosciences(COGT)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001306550-23-007060 Act: 34 Size: 13 KB 网页链接

持股变动声明

$Cogent Biosciences(COGT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-23-000615 Size: 5 KB 网页链接

持股变动声明

$Cogent Biosciences(COGT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-23-000619 Size: 5 KB 网页链接

当期报告

$Cogent Biosciences(COGT)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001193125-22-302302 Act: 34 Size: 9 MB 网页链接

季度财报

$Cogent Biosciences(COGT)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0000950170-22-024685 Act: 34 Size: 7 MB 网页链接

当期报告

$Cogent Biosciences(COGT)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0000950170-22-024675 Act: 34 Size: 535 KB 网页链接

持股变动声明

$Cogent Biosciences(COGT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-032672 Size: 5 KB 网页链接

持股变动声明

$Cogent Biosciences(COGT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-032661 Size: 5 KB 网页链接

超过5%股东持股披露

$Cogent Biosciences(COGT)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-22-097869 Act: 34 Size: 75 KB 网页链接

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21